Personalized Medicine – News and Features

Scientists have identified mutated immune cell clones that drive intestinal inflammation in people with celiac disease, explaining why a gluten-free diet sometimes fails.

Researchers have created a groundbreaking 3D-printed artificial tumor tissue capable of replicating the in vivo conditions of patient-derived cancer cells, which can be used to predict prognosis.

A first-of-its-kind GWAS study has identified two genetic variants linked to breast cancer in black South African women.

Researchers have now substantiated that certain skin bacteria can protect us from the sun’s ultraviolet radiation, specifically by metabolizing cis-urocanic acid using an enzyme called urocanase.

The results of an international study shed new light on the underlying biological mechanisms that cause differences in health risks, symptoms and outcomes between males and females.

New research led by Irish scientists has uncovered how lipid-rich fluid in the abdomen, known as ascites, plays a central role in weakening the body’s immune response in advanced ovarian cancer.

Discover how next-generation sequencing is transforming diagnostics, guiding treatment decisions and shaping the future of personalized medicine.

In this interview, we spoke with Janne Lehtiö, PhD, professor of medical proteomics, to explore how molecular phenotyping and omics-based technologies are reshaping our understanding of disease mechanisms.

Catching up at the Nordic Precision Medicine Forum 2025 in Stockholm, Technology Networks spoke to Astrid Pedersen, special advisor at the Danish National Genome Center, to learn more about the initiative’s work.

Researchers have found that drug effectiveness, alcohol tolerance and carbohydrate metabolism change with the seasons in non-human primates.